PDCD1 and cancer: Among the checkpoints, programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) are targets initially identified for ICI due to their involvement in immune responses to cancer.